Science Explorer Back to mapMap
Discussion
Researcher · Instituto Alexander Fleming · Argentina

Diego Hernán Enrico

Diego Hernán Enrico publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0003-4121-6855 OpenAlex
World rank
#4,761,011
of 7,710,434 ranked researchers
Rank in Argentina
#14,356
of 38,473
Works
75
Citations
755
Citations per work
10.1
h-index
12
i10-index 16Top 42% in Pulmonary and Respiratory Medicine
Diego Hernán Enrico

What does Diego Hernán Enrico research?

Diego Hernán Enrico's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 43 works · 56.8% of their workMedicine: 43 works · 56.8% of their workPulmonary and Respiratory Medicine: 18 works · 23.6% of their workOncology: 17 works · 22.7% of their workSurgery: 4 works · 5.5% of their workPathology and Forensic Medicine: 4 works · 5.0% of their workEverything else: 21 works · 28.6% of their workLife Sciences: 11 works · 14.6% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 14.6% of their workCancer Research: 7 works · 9.1% of their workMolecular Biology: 4 works · 5.5% of their workTHEIR WORKDiego HernánEnrico75works
Life Sciences15%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4356.8%
  2. Everything else2128.6%
    1. Biochemistry, Genetics and Molecular Biology1114.6%
  1. 1Pulmonary and Respiratory Medicine24% of their works
  2. 2Oncology23% of their works
  3. 3Cancer Research9% of their works
  4. 4Molecular Biology6% of their works
  5. 5Surgery6% of their works
  6. 6Pathology and Forensic Medicine5% of their works

Research topics

Which keywords describe Diego Hernán Enrico's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Cancer Genomics, Mutational Signatures and Radiotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy493 topics
  2. Clinical Trials352 topics
  3. Chemotherapy273 topics
  4. ALK Inhibitors241 topic
  5. EGFR Mutations241 topic
  6. Cancer Genomics141 topic
  7. Mutational Signatures141 topic
  8. Radiotherapy142 topics
  9. Immune Checkpoint Blockade131 topic
  10. PD-1 and PD-L1131 topic
  11. Molecular Subtypes122 topics
  12. Genomic Profiles111 topic
  13. Small-Cell Lung Cancer111 topic
  14. CT Screening91 topic
  15. Lung Cancer91 topic
  16. Cetuximab71 topic
  17. KRAS Mutations71 topic
  18. Microsatellite Instability61 topic
  19. Molecular Characterization61 topic
  20. Breast Tumours51 topic
  21. Gene Expression51 topic

Where does Diego Hernán Enrico work?

Diego Hernán Enrico's main affiliation in the publication record is Instituto Alexander Fleming, Argentina.

How many publications and citations does Diego Hernán Enrico have?

OpenAlex counts 75 works and 755 citations for Diego Hernán Enrico, an h-index of 12, ranking #4,761,011 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Diego Hernán Enrico. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.